ArticlePharmaceutics2024

Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy.

Eun-Jeong Won et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.